8.1 Introduction to ICH E6 GCP Principles (including R3 updates)

Introduction to ICH E6 GCP Principles

Good Clinical Practice (GCP) is the universal standard for clinical trials. The International Council for Harmonisation (ICH) developed the ICH E6 guideline to provide a unified standard for the European Union, Japan, and the United States to facilitate the mutual acceptance of clinical data by the regulatory authorities in these jurisdictions. As a Clinical Research Coordinator (CRC), a profound understanding of these principles is not just regulatory requirement—it is the bedrock of your daily professional conduct.

The Core Principles of GCP

ICH E6 outlines several core principles that govern clinical research. These can be broadly categorized into three domains: Ethics, Science, and Quality.

Ethical Principles

1. Primacy of Subject Safety: The rights, safety, and well-being of the trial subjects are the most important considerations and should prevail over interests of science and society. This principle is rooted in the Declaration of Helsinki.
2. IRB/IEC Approval: Before a trial is initiated, foreseeable risks and inconveniences should be weighed against the anticipated benefit for the individual trial subject and society. A trial should be initiated and continued only if the anticipated benefits justify the risks. Freely given informed consent must be obtained from every subject prior to clinical trial participation.
3. Medical Care: The medical care given to, and medical decisions made on behalf of, subjects should always be the responsibility of a qualified physician or, when appropriate, of a qualified dentist.

Scientific and Protocol Principles

1. Scientific Soundness: Clinical trials should be scientifically sound, and described in a clear, detailed protocol. The available nonclinical and clinical information on an investigational product should be adequate to support the proposed clinical trial.
2. Protocol Compliance: A trial should be conducted in compliance with the protocol that has received prior institutional review board (IRB) or independent ethics committee (IEC) approval.
3. Qualified Personnel: Each individual involved in conducting a trial should be qualified by education, training, and experience to perform his or her respective task(s).

Quality and Data Integrity Principles

1. Accurate Reporting: All clinical trial information should be recorded, handled, and stored in a way that allows its accurate reporting, interpretation, and verification.
2. Confidentiality: The confidentiality of records that could identify subjects should be protected, respecting the privacy and confidentiality rules in accordance with the applicable regulatory requirement(s).
3. Good Manufacturing Practice (GMP): Investigational products should be manufactured, handled, and stored in accordance with applicable good manufacturing practice (GMP) and should be used in accordance with the approved protocol.
4. Quality Systems: Systems with procedures that assure the quality of every aspect of the trial should be implemented.

The Evolution to ICH E6(R3)

The clinical research landscape has transformed dramatically since the original ICH E6 guideline was adopted in 1996. The previous R2 update in 2016 introduced risk-based quality management. ICH finalized the E6(R3) guideline on January 6, 2025, and ACRP adopted E6(R3) as the GCP reference for all certification examinations effective July 15, 2026 — replacing E6(R2). R3 modernizes the guideline to address the increasing diversity of clinical trial designs and data sources, including decentralized trials, pragmatic trials, and the incorporation of real-world data (RWD).

Key Updates in R3

Applying GCP in Daily Coordination

As a CRC, GCP principles are applied continuously:

• During Screening: Ensuring the patient signs the IRB-approved consent form before any trial-specific procedures occur (Ethical principle).
• During Visits: Documenting vital signs and adverse events exactly as they happened and entering them promptly into the Electronic Data Capture (EDC) system (Data integrity principle).
• During Drug Dispensing: Storing the investigational product at the correct temperature and keeping precise logs of dispensation and return (GMP principle).

Failure to adhere to GCP can result in regulatory warning letters, rejection of trial data, and, most importantly, harm to trial participants. The CRC serves as the vital link between the theoretical principles of GCP and their practical execution at the clinical site.